AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch

AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch
AFT's Chinese licensee Hainan Haiyao is doing the groundwork for its China launch. (Image: AFT)
Rebecca Stevenson
AFT Pharmaceuticals' Chinese licensee is ramping up efforts to promote its first aid cream Crystaderm to Chinese consumers. Chinese firm Hainan Haiyao Co will get its first shipment of Crystaderm at the end of this calendar year.  AFT Pharmaceuticals co-founder and managing director Dr Hartley Atkinson said the Chinese company was laying the groundwork for the product launch now. Atkinson said Shenzhen Stock Exchange-listed Hainan Haiyao had representatives meeting with doctors to raise awareness of the New Zealand produ...

More Markets

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Contact Energy expands global investor base
Markets

Contact Energy expands global investor base

Contact Energy priced an inaugural €500 million (NZ$1.01b) 7-year senior bond under its Euro Medium Term Note (EMTN) Programme, it said Friday.“This marks a milestone in Contact’s funding strategy, expanding our global investor base and reinforcing our commitment to sustainable f...

Rebecca Howard 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Fonterra windfall brings risks: ASB
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Rebecca Howard 24 Oct 2025